Quick Answer
Regenerative Medical Technology Group Inc. reported Total Revenue of $4.11 million for the year ending 2024.
- Regenerative Medical Technology Group Inc. showed an increase of +70.4% in Total Revenue from 2023 to 2024.
- This data is from Regenerative Medical Technology Group Inc.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
- XBRL data for this metric is available from 2017 to 2024 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: $17.7 thousand | Q2 2018: $8.9 thousand | Q3 2018: $11.7 thousand | Q1 2019: $11.9 thousand | Q2 2019: $7.2 thousand | Q3 2019: $6.2 thousand | Q1 2020: $11.3 thousand | Q2 2020: $28.8 thousand | Q3 2020: $12.3 thousand | Q1 2021: $4.4 thousand | Q2 2021: $15.8 thousand | Q3 2021: $165.0 thousand | Q1 2022: $298.7 thousand | Q2 2022: $297.5 thousand | Q3 2022: $367.7 thousand | Q1 2023: $786.2 thousand | Q2 2023: $361.4 thousand | Q3 2023: $646.8 thousand | Q1 2024: $817.0 thousand | Q2 2024: $793.3 thousand | Q3 2024: $986.3 thousand | Q1 2025: $1.36 million | Q2 2025: $983.5 thousand | Q3 2025: $1.18 million.
- Over the full 8 years of available data (2017 to 2024), Regenerative Medical Technology Group Inc.'s Total Revenue has grown by 13,947.0%.
- Historical annual values: Fiscal year 2024: $4.11 million | Fiscal year 2023: $2.41 million | Fiscal year 2022: $1.53 million | Fiscal year 2021: $437.9 thousand | Fiscal year 2020: $55.1 thousand | Fiscal year 2019: $30.1 thousand | Fiscal year 2018: $50.1 thousand | Fiscal year 2017: $29.2 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: